A Web-Based Tool to Help People With Health Conditions Make Contraceptive Decisions
Launched by UNIVERSITY OF MICHIGAN · Jul 9, 2025
Trial Information
Current as of July 24, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Fourteen outpatient clinics in the United States that provide birth control services, including primary care and obstetrics and gynecology clinics, will be enrolled. Each clinic will be randomly assigned to the My Health My Choice Group (intervention group) or the Usual Care group. Only patients who receive health care at enrolled clinics are eligible for study participation.
Participants must be aged 18-49 years, read English, fertile (able to get pregnant), have at least one health condition or prior pregnancy complication and/or currently take a medicine that may interact with hormonal ...
Gender
FEMALE
Eligibility criteria
- Patient Inclusion Criteria:
- • Between the ages of 18 and 49
- • Assigned female sex at birth
- • Presumed to be fertile (have an intact uterus/tube/ovary; premenopausal)
- • Have at least one health condition, prior adverse pregnancy outcome, taking a teratogenic medication, or taking a medication that has interactions with hormonal contraception
- • Able to read in English
- • Access to mobile phone, computer, or tablet with internet capabilities
- • Not currently pregnant
- • Desire to talk to their clinician about starting, switching, or adding a contraceptive method for the purpose of preventing pregnancy
- Patient Exclusion Criteria:
- • Trying to get pregnant in the next 12 months
- • Presumed infertile for any surgical or medical reason (e.g., postmenopausal, hysterectomy, chemotherapy)
- • There are additional clarifications regarding patient eligibility, such as a full list of eligible medical diagnoses and medicines, that can be found in the protocol.
- Clinician Inclusion Criteria:
- • • Any licensed clinician who provides contraceptive care at a participating clinic, including physicians, physician assistants, certified nurse midwives, nurse practitioners. (For clinicians, there are no restrictions based upon age, gender identify or sex).
- Clinician Exclusion Criteria:
- • • Physician interns (PGY-1) are not eligible
About University Of Michigan
The University of Michigan, a leading academic institution renowned for its commitment to advancing healthcare and medical research, serves as a prominent clinical trial sponsor. With a robust infrastructure that supports innovative research initiatives, the university leverages its multidisciplinary expertise to conduct a wide array of clinical trials aimed at improving patient outcomes and advancing medical knowledge. Through its state-of-the-art facilities and collaborative environment, the University of Michigan fosters partnerships between researchers, clinicians, and industry leaders, ensuring the development of cutting-edge therapies and interventions that address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Pomona, California, United States
Phoenix, Arizona, United States
Kansas City, Kansas, United States
Sanford, Maine, United States
Boston, Massachusetts, United States
Ann Arbor, Michigan, United States
Kalamazoo, Michigan, United States
Ypsilanti, Michigan, United States
New Brunswick, New Jersey, United States
Cleveland, Ohio, United States
Salt Lake City, Utah, United States
Morgantown, West Virginia, United States
Patients applied
Trial Officials
Justine P Wu, MD, MPH
Principal Investigator
Department of Family Medicine, University of Michigan
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported